List of Scitara DLX Customers
Marlborough, 01752, MA,
United States
Since 2010, our global team of researchers has been studying Scitara DLX customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Scitara DLX for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Scitara DLX for Laboratory Management include: Pfizer, a United States based Life Sciences organisation with 81000 employees and revenues of $63.63 billion, Boehringer Ingelheim, a Germany based Life Sciences organisation with 54500 employees and revenues of $28.94 billion, Gilead Sciences, a United States based Life Sciences organisation with 17600 employees and revenues of $28.75 billion, Medline, a United States based Life Sciences organisation with 38000 employees and revenues of $21.20 billion, Teva Pharmaceuticals, a Israel based Life Sciences organisation with 35001 employees and revenues of $15.85 billion and many others.
Contact us if you need a completed and verified list of companies using Scitara DLX, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Scitara DLX customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
argenx | Life Sciences | 650 | $381M | Netherlands | Scitara | Scitara DLX | Laboratory Management | 2022 | n/a |
In 2022, argenx implemented Scitara DLX as its Laboratory Management platform, deploying the application to support research and laboratory operations. The deployment tied the company, Scitara DLX and Laboratory Management to core R&D workflows, establishing a formal platform for laboratory data orchestration and operational control across its scientific teams.
Scitara DLX was configured to provide sample lifecycle management, instrument connectivity, data orchestration and workflow automation, reflecting capabilities typical of Laboratory Management solutions. Configuration work focused on instrument interfacing, protocol and run management, and structured data capture to support laboratory execution and downstream analysis.
Governance changes accompanied the rollout to standardize laboratory workflows and data governance, aligning cross-functional processes between scientists and lab operations. argenx presented this implementation and its implementation journey alongside Teva Pharmaceuticals and Boehringer Ingelheim to share the impact Scitara DLX has had on their digital transformation.
|
 |
Astellas Pharma US | Life Sciences | 3000 | $700M | United States | Scitara | Scitara DLX | Laboratory Management | 2019 | n/a |
In 2019, Astellas Pharma US implemented Scitara DLX to support Laboratory Management across its research and technical operations labs and production environments. The deployment was aligned with site level automation ownership in South San Francisco and with cross functional stakeholders in Quality Assurance, Quality Control, Process Development, IT and Facilities, positioning Scitara DLX to centralize instrument connectivity and data capture for GxP workflows.
Configuration work focused on device adapters and protocol bridges for PLCs, SCADA, DCS, OPC DA UA and MODBUS, with services for instrument abstraction, event driven data collection, metadata normalization and secure RDBMS persistence. Functional modules included system administration, device management, real time data capture and historian interfaces, API endpoints for analytics consumption, and dashboarding capabilities embedded within Scitara DLX.
Integrations were implemented to federate data with Aveva PI suite components and enterprise historians, and to feed downstream analytics platforms such as Spotfire and Power BI, alongside ELN and laboratory data platforms including Benchling and Tetrascience. The architecture incorporated cloud technologies such as Azure or AWS for storage and compute, RDBMS backends for normalized results, and OPC UA for secure device telemetry, while ingesting data from laboratory instruments including Cytiva Unicorn and Sartorius BioBrain.
Governance and operationalization emphasized compliance with GAMP and 21 CFR Part 11, and included authoring Functional Specifications, Design Specifications, Configuration Specifications and Automation SOPs. Change Controls, Deviations and CAPAs for automation related changes were managed by automation and quality teams, Level 3 and above technical support was defined for real time processing and controls issues, and automation test protocols and computer system validation practices were embedded into rollout and ongoing operations.
|
 |
Boehringer Ingelheim | Life Sciences | 54500 | $28.9B | Germany | Scitara | Scitara DLX | Laboratory Management | 2022 | n/a |
In 2022, Boehringer Ingelheim deployed Scitara DLX as a Laboratory Management platform. The implementation positioned Scitara DLX as a centralized data orchestration and instrument connectivity layer to support laboratory operations within research and development.
Scitara DLX was implemented to provide core Laboratory Management capabilities including instrument connectivity, data acquisition and normalization, event-driven workflow orchestration, and audit-ready data logging. Configuration work emphasized protocol adapters and API-ready endpoints typical for laboratory automation, and metadata mapping to preserve data provenance and lineage in laboratory workflows.
Operational focus targeted internal laboratory and R&D functions, where Scitara DLX was used to standardize data capture, automate instrument orchestration, and enforce consistent governance around experiment data handling. The Boehringer Ingelheim Scitara DLX Laboratory Management deployment aligned technical architecture, workflow orchestration, and governance to create a repeatable pattern for lab-level data management.
|
 |
|
Life Sciences | 10000 | $4.8B | Japan | Scitara | Scitara DLX | Laboratory Management | 2021 | n/a |
|
|
|
|
Life Sciences | 2000 | $450M | United States | Scitara | Scitara DLX | Laboratory Management | 2024 | n/a |
|
|
|
|
Life Sciences | 17600 | $28.8B | United States | Scitara | Scitara DLX | Laboratory Management | 2023 | n/a |
|
|
|
|
Life Sciences | 20 | $3M | United States | Scitara | Scitara DLX | Laboratory Management | 2023 | n/a |
|
|
|
|
Life Sciences | 15000 | $6.0B | United States | Scitara | Scitara DLX | Laboratory Management | 2019 | n/a |
|
|
|
|
Professional Services | 150 | $17M | United States | Scitara | Scitara DLX | Laboratory Management | 2019 | n/a |
|
|
|
|
Life Sciences | 38000 | $21.2B | United States | Scitara | Scitara DLX | Laboratory Management | 2018 | n/a |
|
Buyer Intent: Companies Evaluating Scitara DLX
- Regeneron Pharmaceuticals, a United States based Life Sciences organization with 15182 Employees
- Hanmi Pharm, a South Korea based Life Sciences company with 2400 Employees
- Fujitsu, a Japan based Manufacturing organization with 113000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||